APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acute Agitation and Aggression Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Acute Agitation and Aggression Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026184 pages

Choose your research edition.

Industry ResearchAcute Agitation and Aggression Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Agitation and Aggression Drugs Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Acute Agitation and Aggression Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Agitation and Aggression Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Agitation and Aggression Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Acute Agitation and Aggression Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Acute Agitation and Aggression Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acute Agitation and Aggression Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acute Agitation and Aggression Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Acute Agitation and Aggression Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acute Agitation and Aggression Drugs include Bristol-Myers Squibb, H. Lundbeck A/S, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Pfizer, Eli Lilly and Company and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Acute Agitation and Aggression Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acute Agitation and Aggression Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acute Agitation and Aggression Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Acute Agitation and Aggression Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Acute Agitation and Aggression Drugs Segment by Company

Bristol-Myers Squibb

H. Lundbeck A/S

Ono Pharmaceutical

Otsuka Holdings

GlaxoSmithKline

Pfizer

Eli Lilly and Company

Johnson & Johnson

Acute Agitation and Aggression Drugs Segment by Type

Oral

Intramuscular Injection

Others

Acute Agitation and Aggression Drugs Segment by Application

Hospitals & Ambulatory Surgical Centers

Psychiatric Care Facilities

Others

Acute Agitation and Aggression Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Agitation and Aggression Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Agitation and Aggression Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Agitation and Aggression Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Acute Agitation and Aggression Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acute Agitation and Aggression Drugs industry.

Chapter 3: Detailed analysis of Acute Agitation and Aggression Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acute Agitation and Aggression Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Table 3. Key Players of Intramuscular Injection Table 4. Key Players of Others Table 4. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals & Ambulatory Surgical Centers Table 6. Key Players of Psychiatric Care Facilities Table 7. Key Players of Others Table 8. Global Acute Agitation and Aggression Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Acute Agitation and Aggression Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Acute Agitation and Aggression Drugs Market Share by Region (2021-2026) Table 11. Global Acute Agitation and Aggression Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Acute Agitation and Aggression Drugs Market Share by Region (2027-2032) Table 13. Acute Agitation and Aggression Drugs Industry Trends Table 14. Acute Agitation and Aggression Drugs Industry Drivers Table 15. Acute Agitation and Aggression Drugs Industry Opportunities and Challenges Table 16. Acute Agitation and Aggression Drugs Industry Restraints Table 17. Global Acute Agitation and Aggression Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Acute Agitation and Aggression Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Acute Agitation and Aggression Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Acute Agitation and Aggression Drugs Key Company Head Office and Area Served Table 21. Global Acute Agitation and Aggression Drugs Company, Product Type & Application Table 22. Global Acute Agitation and Aggression Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Acute Agitation and Aggression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Acute Agitation and Aggression Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Acute Agitation and Aggression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Acute Agitation and Aggression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Acute Agitation and Aggression Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Acute Agitation and Aggression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Acute Agitation and Aggression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2027-2032) Table 35. Bristol-Myers Squibb Company Information Table 36. Bristol-Myers Squibb Business Overview Table 37. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product Portfolio Table 39. Bristol-Myers Squibb Recent Development Table 40. H. Lundbeck A/S Company Information Table 41. H. Lundbeck A/S Business Overview Table 42. H. Lundbeck A/S Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. H. Lundbeck A/S Acute Agitation and Aggression Drugs Product Portfolio Table 44. H. Lundbeck A/S Recent Development Table 45. Ono Pharmaceutical Company Information Table 46. Ono Pharmaceutical Business Overview Table 47. Ono Pharmaceutical Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Ono Pharmaceutical Acute Agitation and Aggression Drugs Product Portfolio Table 49. Ono Pharmaceutical Recent Development Table 50. Otsuka Holdings Company Information Table 51. Otsuka Holdings Business Overview Table 52. Otsuka Holdings Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Otsuka Holdings Acute Agitation and Aggression Drugs Product Portfolio Table 54. Otsuka Holdings Recent Development Table 55. GlaxoSmithKline Company Information Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Acute Agitation and Aggression Drugs Product Portfolio Table 59. GlaxoSmithKline Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pfizer Acute Agitation and Aggression Drugs Product Portfolio Table 64. Pfizer Recent Development Table 65. Eli Lilly and Company Company Information Table 66. Eli Lilly and Company Business Overview Table 67. Eli Lilly and Company Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Eli Lilly and Company Acute Agitation and Aggression Drugs Product Portfolio Table 69. Eli Lilly and Company Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Johnson & Johnson Acute Agitation and Aggression Drugs Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. North America Acute Agitation and Aggression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Acute Agitation and Aggression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Acute Agitation and Aggression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Acute Agitation and Aggression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Acute Agitation and Aggression Drugs Market Size by Country (2021-2026) Table 81. North America Acute Agitation and Aggression Drugs Market Size by Country (2027-2032) Table 82. Europe Acute Agitation and Aggression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Acute Agitation and Aggression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Acute Agitation and Aggression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Acute Agitation and Aggression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Acute Agitation and Aggression Drugs Market Size by Country (2021-2026) Table 88. Europe Acute Agitation and Aggression Drugs Market Size by Country (2027-2032) Table 89. China Acute Agitation and Aggression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 90. China Acute Agitation and Aggression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 91. China Acute Agitation and Aggression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 92. China Acute Agitation and Aggression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Acute Agitation and Aggression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Acute Agitation and Aggression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Acute Agitation and Aggression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Acute Agitation and Aggression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Acute Agitation and Aggression Drugs Market Size by Country (2021-2026) Table 99. Asia Acute Agitation and Aggression Drugs Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Acute Agitation and Aggression Drugs Product Image Figure 2. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Acute Agitation and Aggression Drugs Market Share by Type: 2025 VS 2032 Figure 4. Oral Image Figure 5. Intramuscular Injection Image Figure 6. Others Image Figure 7. Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Acute Agitation and Aggression Drugs Market Share by Application: 2025 VS 2032 Figure 9. Hospitals & Ambulatory Surgical Centers Image Figure 10. Psychiatric Care Facilities Image Figure 11. Others Image Figure 12. Global Acute Agitation and Aggression Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 14. Global Acute Agitation and Aggression Drugs Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Acute Agitation and Aggression Drugs Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Acute Agitation and Aggression Drugs Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Acute Agitation and Aggression Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Acute Agitation and Aggression Drugs Revenue Market Share by Type (2021-2032) Figure 21. Global Acute Agitation and Aggression Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Acute Agitation and Aggression Drugs Revenue Market Share by Application (2021-2032) Figure 23. North America Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 24. North America Acute Agitation and Aggression Drugs Market Share by Type (2021-2032) Figure 25. North America Acute Agitation and Aggression Drugs Market Share by Application (2021-2032) Figure 26. North America Acute Agitation and Aggression Drugs Market Share by Country (2021-2032) Figure 27. United States Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 28. Canada Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Europe Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Acute Agitation and Aggression Drugs Market Share by Type (2021-2032) Figure 32. Europe Acute Agitation and Aggression Drugs Market Share by Application (2021-2032) Figure 33. Europe Acute Agitation and Aggression Drugs Market Share by Country (2021-2032) Figure 34. Germany Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 35. France Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Italy Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Russia Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 40. China Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Acute Agitation and Aggression Drugs Market Share by Type (2021-2032) Figure 42. China Acute Agitation and Aggression Drugs Market Share by Application (2021-2032) Figure 43. Asia Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 44. Asia Acute Agitation and Aggression Drugs Market Share by Type (2021-2032) Figure 45. Asia Acute Agitation and Aggression Drugs Market Share by Application (2021-2032) Figure 46. Asia Acute Agitation and Aggression Drugs Market Share by Country (2021-2032) Figure 47. Japan Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 51. India Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 52. Australia Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Country (2021-2032) Figure 57. Brazil Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 62. UAE Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Chile Acute Agitation and Aggression Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Intramuscular Injection
  • Others
Applications
  • Hospitals & Ambulatory Surgical Centers
  • Psychiatric Care Facilities
  • Others
Companies covered
  • Bristol-Myers Squibb
  • H. Lundbeck A/S
  • Ono Pharmaceutical
  • Otsuka Holdings
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly and Company
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Intramuscular Injection
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Acute Agitation and Aggression Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals & Ambulatory Surgical Centers
  10. 1.3.3 Psychiatric Care Facilities
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Acute Agitation and Aggression Drugs Growth Trends by Region
  14. 1.5.1 Global Acute Agitation and Aggression Drugs Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Acute Agitation and Aggression Drugs Market Size by Region (2021-2026)
  16. 1.5.3 Acute Agitation and Aggression Drugs Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Acute Agitation and Aggression Drugs Market Dynamics
  1. 2.1 Acute Agitation and Aggression Drugs Industry Trends
  2. 2.2 Acute Agitation and Aggression Drugs Industry Drivers
  3. 2.3 Acute Agitation and Aggression Drugs Industry Opportunities and Challenges
  4. 2.4 Acute Agitation and Aggression Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Acute Agitation and Aggression Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Acute Agitation and Aggression Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Acute Agitation and Aggression Drugs Key Company Head office and Area Served
  4. 3.4 Global Acute Agitation and Aggression Drugs Company, Product Type & Application
  5. 3.5 Global Acute Agitation and Aggression Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Acute Agitation and Aggression Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Acute Agitation and Aggression Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Acute Agitation and Aggression Drugs Tier 1, Tier 2, and Tier 3
4 Acute Agitation and Aggression Drugs Market by Type
  1. 4.1 Global Acute Agitation and Aggression Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Acute Agitation and Aggression Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Acute Agitation and Aggression Drugs Market Size Share by Type (2021-2032)
5 Acute Agitation and Aggression Drugs Market by Application
  1. 5.1 Global Acute Agitation and Aggression Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Acute Agitation and Aggression Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Acute Agitation and Aggression Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 H. Lundbeck A/S
  8. 6.2.1 H. Lundbeck A/S Company Information
  9. 6.2.2 H. Lundbeck A/S Business Overview
  10. 6.2.3 H. Lundbeck A/S Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 H. Lundbeck A/S Acute Agitation and Aggression Drugs Product Portfolio
  12. 6.2.5 H. Lundbeck A/S Recent Developments
  13. 6.3 Ono Pharmaceutical
  14. 6.3.1 Ono Pharmaceutical Company Information
  15. 6.3.2 Ono Pharmaceutical Business Overview
  16. 6.3.3 Ono Pharmaceutical Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ono Pharmaceutical Acute Agitation and Aggression Drugs Product Portfolio
  18. 6.3.5 Ono Pharmaceutical Recent Developments
  19. 6.4 Otsuka Holdings
  20. 6.4.1 Otsuka Holdings Company Information
  21. 6.4.2 Otsuka Holdings Business Overview
  22. 6.4.3 Otsuka Holdings Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Otsuka Holdings Acute Agitation and Aggression Drugs Product Portfolio
  24. 6.4.5 Otsuka Holdings Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Acute Agitation and Aggression Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer Acute Agitation and Aggression Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Eli Lilly and Company
  38. 6.7.1 Eli Lilly and Company Company Information
  39. 6.7.2 Eli Lilly and Company Business Overview
  40. 6.7.3 Eli Lilly and Company Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eli Lilly and Company Acute Agitation and Aggression Drugs Product Portfolio
  42. 6.7.5 Eli Lilly and Company Recent Developments
  43. 6.8 Johnson & Johnson
  44. 6.8.1 Johnson & Johnson Company Information
  45. 6.8.2 Johnson & Johnson Business Overview
  46. 6.8.3 Johnson & Johnson Acute Agitation and Aggression Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Johnson & Johnson Acute Agitation and Aggression Drugs Product Portfolio
  48. 6.8.5 Johnson & Johnson Recent Developments
7 North America
  1. 7.1 North America Acute Agitation and Aggression Drugs Market Size (2021-2032)
  2. 7.2 North America Acute Agitation and Aggression Drugs Market Size by Type
  3. 7.2.1 North America Acute Agitation and Aggression Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Acute Agitation and Aggression Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Acute Agitation and Aggression Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Acute Agitation and Aggression Drugs Market Size by Application
  7. 7.3.1 North America Acute Agitation and Aggression Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Acute Agitation and Aggression Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Acute Agitation and Aggression Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Acute Agitation and Aggression Drugs Market Size by Country
  11. 7.4.1 North America Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Acute Agitation and Aggression Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Acute Agitation and Aggression Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Acute Agitation and Aggression Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Acute Agitation and Aggression Drugs Market Size (2021-2032)
  2. 8.2 Europe Acute Agitation and Aggression Drugs Market Size by Type
  3. 8.2.1 Europe Acute Agitation and Aggression Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Acute Agitation and Aggression Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Acute Agitation and Aggression Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Acute Agitation and Aggression Drugs Market Size by Application
  7. 8.3.1 Europe Acute Agitation and Aggression Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Acute Agitation and Aggression Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Acute Agitation and Aggression Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Acute Agitation and Aggression Drugs Market Size by Country
  11. 8.4.1 Europe Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Acute Agitation and Aggression Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Acute Agitation and Aggression Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Acute Agitation and Aggression Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Acute Agitation and Aggression Drugs Market Size (2021-2032)
  2. 9.2 China Acute Agitation and Aggression Drugs Market Size by Type
  3. 9.2.1 China Acute Agitation and Aggression Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Acute Agitation and Aggression Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Acute Agitation and Aggression Drugs Market Share by Type (2021-2032)
  6. 9.3 China Acute Agitation and Aggression Drugs Market Size by Application
  7. 9.3.1 China Acute Agitation and Aggression Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Acute Agitation and Aggression Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Acute Agitation and Aggression Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Acute Agitation and Aggression Drugs Market Size (2021-2032)
  2. 10.2 Asia Acute Agitation and Aggression Drugs Market Size by Type
  3. 10.2.1 Asia Acute Agitation and Aggression Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Acute Agitation and Aggression Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Acute Agitation and Aggression Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Acute Agitation and Aggression Drugs Market Size by Application
  7. 10.3.1 Asia Acute Agitation and Aggression Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Acute Agitation and Aggression Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Acute Agitation and Aggression Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Acute Agitation and Aggression Drugs Market Size by Country
  11. 10.4.1 Asia Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Acute Agitation and Aggression Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Acute Agitation and Aggression Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Acute Agitation and Aggression Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Acute Agitation and Aggression Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst